Niacin Extended Release Tablets, USP, 500 mg, 90 count bottle, Rx Only, Teva Pharmaceuticals USA, Inc., Sellersville, PA, 18960, NDC 0093-7392-98

FDA recall notice · announced January 8, 2014 · Teva Pharmaceuticals

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Niacin Extended Release Tablets, USP, 500 mg, 90 count bottle, Rx Only, Teva Pharmaceuticals USA, Inc., Sellersville, PA, 18960, NDC 0093-7392-98

Reason for recall

Failed Tablet/Capsule Specifications: There is a potential for broken tablets.

Notes

Distribution: Nationwide and Puerto Rico, American Samoa, Virgin Islands, and Canal Zone
Lot/code information: Lot#: 32900349B, Exp: 12/2014
Quantity: 10,512 bottles
Status: Terminated
Products in this recall event:
- Niacin Extended Release Tablets, USP, 500 mg, 90 count bottle, Rx Only, Teva Pharmaceuticals USA, Inc., Sellersville, PA, 18960, NDC 0093-7392-98 (D-396-2014)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.